These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 18664944)
1. Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans. Lara AM; Wakholi BN; Kasirye A; Munderi P; Watera C; Lalloo DG; Haycox A; Gilks CF; Grosskurth H AIDS; 2008 Jul; 22 Suppl 1():S123-30. PubMed ID: 18664944 [TBL] [Abstract][Full Text] [Related]
2. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. Kahn JG; Marseille E; Moore D; Bunnell R; Were W; Degerman R; Tappero JW; Ekwaru P; Kaharuza F; Mermin J BMJ; 2011 Nov; 343():d6884. PubMed ID: 22074713 [TBL] [Abstract][Full Text] [Related]
3. Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. Schackman BR; Goldie SJ; Freedberg KA; Losina E; Brazier J; Weinstein MC Med Decis Making; 2002; 22(1):27-38. PubMed ID: 11833663 [TBL] [Abstract][Full Text] [Related]
4. Economic methods for measuring the quality of life associated with HIV infection. Bayoumi AM; Redelmeier DA Qual Life Res; 1999 Sep; 8(6):471-80. PubMed ID: 10548862 [TBL] [Abstract][Full Text] [Related]
5. Initiation of antiretroviral therapy based on the 2015 WHO guidelines. Kuznik A; Iliyasu G; Habib AG; Musa BM; Kambugu A; Lamorde M AIDS; 2016 Nov; 30(18):2865-2873. PubMed ID: 27662547 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer. Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439 [TBL] [Abstract][Full Text] [Related]
8. When to start antiretroviral therapy in resource-limited settings. Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E; Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143 [TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease. Joyce VR; Barnett PG; Bayoumi AM; Griffin SC; Kyriakides TC; Yu W; Sundaram V; Holodniy M; Brown ST; Cameron W; Youle M; Sculpher M; Anis AH; Owens DK J Acquir Immune Defic Syndr; 2009 Jan; 50(1):27-36. PubMed ID: 19295332 [TBL] [Abstract][Full Text] [Related]
10. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings. Bishai D; Colchero A; Durack DT AIDS; 2007 Jun; 21(10):1333-40. PubMed ID: 17545710 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Iwuji CC; Orne-Gliemann J; Tanser F; Boyer S; Lessells RJ; Lert F; Imrie J; Bärnighausen T; Rekacewicz C; Bazin B; Newell ML; Dabis F; Trials; 2013 Jul; 14():230. PubMed ID: 23880306 [TBL] [Abstract][Full Text] [Related]
12. Health values of patients with systemic sclerosis. Khanna D; Ahmed M; Furst DE; Ginsburg SS; Park GS; Hornung R; Tsevat J Arthritis Rheum; 2007 Feb; 57(1):86-93. PubMed ID: 17266070 [TBL] [Abstract][Full Text] [Related]
13. Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients. Rashidi AA; Anis AH; Marra CA Health Qual Life Outcomes; 2006 Apr; 4():25. PubMed ID: 16626489 [TBL] [Abstract][Full Text] [Related]
14. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. Venkataramani AS; Thirumurthy H; Haberer JE; Ii YB; Siedner MJ; Kembabazi A; Hunt PW; Martin JN; Bangsberg DR; Tsai AC AIDS; 2014 May; 28(8):1221-6. PubMed ID: 24406678 [TBL] [Abstract][Full Text] [Related]
15. The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation. Matza LS; Boye KS; Feeny DH; Bowman L; Johnston JA; Stewart KD; McDaniel K; Jordan J Eur J Health Econ; 2016 Nov; 17(8):979-990. PubMed ID: 26611792 [TBL] [Abstract][Full Text] [Related]
16. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. Mermin J; Ekwaru JP; Were W; Degerman R; Bunnell R; Kaharuza F; Downing R; Coutinho A; Solberg P; Alexander LN; Tappero J; Campbell J; Moore DM BMJ; 2011 Nov; 343():d6792. PubMed ID: 22074711 [TBL] [Abstract][Full Text] [Related]
18. Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population. Kim SH; Lee SI; Jo MW Qual Life Res; 2017 Dec; 26(12):3387-3397. PubMed ID: 28801862 [TBL] [Abstract][Full Text] [Related]
19. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Siegfried N; Uthman OA; Rutherford GW Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364 [TBL] [Abstract][Full Text] [Related]